Mild cognitive impairment: Incidence and vascular risk factors in a population-based cohort

Neurology

Volumn 80, Issue 23, 2013, Pages 2112-2120

  Ganguli, Mary ^a,b   Fu, Bo ^a,b   Snitz, Beth E ^a   Hughes, Tiffany F ^a   Chang, Chung Chou H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; LIPOPROTEIN;

AGED; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BRAIN FUNCTION; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COGNITION; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENOTYPE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SURVIVAL RATE;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MILD COGNITIVE IMPAIRMENT; MODELS, STATISTICAL; NEUROPSYCHOLOGICAL TESTS; PENNSYLVANIA; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; TIME FACTORS;

EID: 84879071041     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318295d776     Document Type: Article

References (40)

1. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years later. Arch Neurol 2009;66: 1447-1455.
2. Ward A, Arrighi HM, Michels S, Cedarbaum JM. Mild cognitive impairment: disparity of incidence and prevalence estimates. Alzheimers Dement 2012;8:14-21.
3. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia: meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;119: 252-265.
4. Ganguli M, Chang C-CH, Snitz BE, et al. Prevalence of mild cognitive impairment by multiple classifications: the MYHAT Project. Am J Geriatr Psychiatry 2010;18: 674-768.
5. Ganguli M, Snitz BE, Saxton JA, et al. Outcomes of mild cognitive impairment by definition: a population study. Arch Neurol 2011;68:761-767.
6. Lopez OL, Becker JT, Chang Y-F, et al. Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study. Neurology 2012;79: 1599-1606.
7. Farias ST, Mungas D, Reed BR, et al. Progression of mild cognitive impairment to dementia in clinic vs communitybased cohorts. Arch Neurol 2009;66:1151-1157.
8. Petersen RC. Does the source of subjects matter? Absolutely! Neurology 2010;74:1754-1755.
9. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 2008:4:363-381.
10. Sahathevan R, Brodtmann A, Donnan GA. Dementia, stroke, and vascular risk factors: a review. Int J Stroke 2012;7:61-73.
11. Unverzagt FW, Ogunniyi A, Taler V, et al. Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans. Alzheimer Dis Assoc Disord 2011;25:4-10.
12. Knopman DS, Penman AD, Catellier DJ, et al. Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology 2011;76:1879-1885.
13. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer's disease and mild cognitive impairment. Ann Neurol 2009;66:200-208.
14. Luchsinger JA, Reitz C, Patel B, et al. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007;64:570-575.
15. Reitz C, Tang MX, Manly J, et al. Hypertension and the risk of mild cognitive impairment. Arch Neurol 2007;64: 1734-1740.
16. Tervo S, Kivilpelto M, Hanninen T, et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 2004;17:196-203.
17. Chang C-CH, Yang H-C, Tang G, Ganguli M.Minimizing attrition bias: a longitudinal study of depressive symptoms in an elderly cohort. Int Psychogeriatr 2009;21:869-878.
18. Chang C-CH, Zhao Y, Lee C-W, Ganguli M. Smoking, death, and Alzheimer's disease: a case of competing risks. Alzheimer Dis Assoc Disord 2012;26:300-306.
19. Wulfsohn MS, Tsiatis AA. A joint model for survival and longitudinal data measured with error. Biometrics 1997; 53:330-339.
20. Little RJA. Pattern-mixture models for multivariate incomplete data. J Am Stat Assoc 1993;88:125-134.
21. Ganguli M, Snitz BE, Lee C-W, et al. Age and education effects and norms on a cognitive test battery from a population-based cohort: the Monongahela-Youghiogheny Healthy Aging Team (MYHAT). Aging Ment Health 2010; 14:109-116.
22. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
23. Mungas D, Marshall SC, Weldon M, et al. Age and education correction of Mini-Mental State Examination for English and Spanish-speaking elderly. Neurology 1996;46:700-706.
24. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1994;46:2412-2414.
25. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early stage Alzheimer's disease. Arch Neurol 2001;58:397-405.
26. Czernichow S, Kengne A-P, Stamatakis E, et al. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk? Evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obes Rev 2011;12:680-687.
27. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.
28. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-2060.
29. Gerstein HC. Glycosylated hemoglobin: finally ready for prime time as a cardiovascular risk factor. Ann Intern Med 2004;141:475-476.
30. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
31. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 2000;20:1057-1060.
32. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data, 2nd ed. New York, NY: Springer-Verlag; 2003.
33. Roberts RO, Geda GE, Knopman DS, et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology 2012;78:342-351.
34. Jack CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathologic cascade. Lancet Neurol 2010;9:119-128.
35. Agarwal DP. Cardioprotective effects of light to moderate alcohol consumption: a review of putative mechanisms. Alcohol Alcohol 2002;37:409-441.
36. Grundy SM, Brewer HB, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004;109:433-438.
37. Luchsinger JA, Cheng D, Tang M-X, et al. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 2012;26:101-105.
38. Panza F, Frisardi V, Seripa D, et al. Metabolic syndrome, mild cognitive impairment, and dementia. Curr Alzheimer Res 2011;8:492-509.
39. Elias MF, Sullivan LM, D'Agostino RB, et al. Framingham stroke risk profile and lowered cognitive performance. Stroke 2004;35:404-409.
40. Miller G. Stopping Alzheimer's before it starts. Science 2012;337:790-792.